GSK
GSK·NYSE
--
--(--)
--
--(--)
4.28 / 10
Netural
GSK's fundamentals are assessed as average (4.3/10). Constructive elements include a healthy interest-coverage ratio (EBIT/Interest expense = 14.91%) and a positive net-income-to-revenue relationship, while limitations are seen in modest operating-revenue growth (4.11% YoY). Historical back-tests indicate mixed returns for each factor, reinforcing the neutral stance.
Analysis Checks(5/10)
Revenue-MV
Value0.37
Score2/3
Weight15.46%
1M Return7.73%
Value0.37
Score2/3
Weight15.46%
1M Return7.73%
Days sales outstanding
Value78.83
Score1/3
Weight-2.17%
1M Return-1.57%
Value78.83
Score1/3
Weight-2.17%
1M Return-1.57%
Net income-Revenue
Value-0.06
Score3/3
Weight18.74%
1M Return9.29%
Value-0.06
Score3/3
Weight18.74%
1M Return9.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value14.91
Score2/3
Weight-1.58%
1M Return-1.11%
Value14.91
Score2/3
Weight-1.58%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight11.25%
1M Return5.75%
Value-0.50
Score0/3
Weight11.25%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value4.11
Score1/3
Weight-1.15%
1M Return-0.79%
Value4.11
Score1/3
Weight-1.15%
1M Return-0.79%
Profit-MV
Value1.36
Score3/3
Weight18.99%
1M Return9.28%
Value1.36
Score3/3
Weight18.99%
1M Return9.28%
PB-ROE
Value0.61
Score1/3
Weight19.18%
1M Return9.57%
Value0.61
Score1/3
Weight19.18%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value4.11
Score1/3
Weight-1.11%
1M Return-0.76%
Value4.11
Score1/3
Weight-1.11%
1M Return-0.76%
Cash-MV
Value0.57
Score3/3
Weight22.41%
1M Return9.67%
Value0.57
Score3/3
Weight22.41%
1M Return9.67%
Revenue-MV
Value0.37
Score2/3
Weight15.46%
1M Return7.73%
Value0.37
Score2/3
Weight15.46%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value4.11
Score1/3
Weight-1.15%
1M Return-0.79%
Value4.11
Score1/3
Weight-1.15%
1M Return-0.79%
Days sales outstanding
Value78.83
Score1/3
Weight-2.17%
1M Return-1.57%
Value78.83
Score1/3
Weight-2.17%
1M Return-1.57%
Profit-MV
Value1.36
Score3/3
Weight18.99%
1M Return9.28%
Value1.36
Score3/3
Weight18.99%
1M Return9.28%
Net income-Revenue
Value-0.06
Score3/3
Weight18.74%
1M Return9.29%
Value-0.06
Score3/3
Weight18.74%
1M Return9.29%
PB-ROE
Value0.61
Score1/3
Weight19.18%
1M Return9.57%
Value0.61
Score1/3
Weight19.18%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value14.91
Score2/3
Weight-1.58%
1M Return-1.11%
Value14.91
Score2/3
Weight-1.58%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value4.11
Score1/3
Weight-1.11%
1M Return-0.76%
Value4.11
Score1/3
Weight-1.11%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight11.25%
1M Return5.75%
Value-0.50
Score0/3
Weight11.25%
1M Return5.75%
Cash-MV
Value0.57
Score3/3
Weight22.41%
1M Return9.67%
Value0.57
Score3/3
Weight22.41%
1M Return9.67%
Is GSK undervalued or overvalued?
- GSK scores 4.28/10 on fundamentals and holds a Fair valuation at present. Backed by its 39.36% ROE, 19.25% net margin, 15.97 P/E ratio, 5.72 P/B ratio, and 139.77% earnings growth, these metrics solidify its Netural investment rating.
